3.51BMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-06-18The current institutional shareholding score of Beam Therapeutics Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 103.20%, representing a quarter-over-quarter decrease of 9.85%. The largest institutional shareholder is Catherine Wood, holding a total of 9.07M shares, representing 12.21% of shares outstanding, with 3.53% increase in holdings.
Institutional Shareholding
Shareholder Activity
Fidelity Management & Research Company LLC
Farallon Capital Management, L.L.C.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Amova Asset Management Co., Ltd.